Barclays PLC Has $208,000 Stake in Stereotaxis, Inc. (NYSEAMERICAN:STXS)

Barclays PLC increased its stake in shares of Stereotaxis, Inc. (NYSEAMERICAN:STXS) by 449.9% in the 3rd quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 101,953 shares of the company’s stock after purchasing an additional 83,412 shares during the quarter. Barclays PLC owned approximately 0.12% of Stereotaxis worth $208,000 as of its most recent filing with the SEC.

Other institutional investors and hedge funds have also recently added to or reduced their stakes in the company. Renaissance Technologies LLC increased its holdings in shares of Stereotaxis by 46.2% during the 2nd quarter. Renaissance Technologies LLC now owns 488,700 shares of the company’s stock valued at $889,000 after acquiring an additional 154,400 shares during the last quarter. Bank of New York Mellon Corp increased its holdings in shares of Stereotaxis by 247.5% during the 2nd quarter. Bank of New York Mellon Corp now owns 189,592 shares of the company’s stock valued at $345,000 after acquiring an additional 135,041 shares during the last quarter. Geode Capital Management LLC increased its holdings in shares of Stereotaxis by 7.2% during the 3rd quarter. Geode Capital Management LLC now owns 1,391,718 shares of the company’s stock valued at $2,840,000 after acquiring an additional 93,253 shares during the last quarter. Rhumbline Advisers increased its holdings in shares of Stereotaxis by 645.6% during the 2nd quarter. Rhumbline Advisers now owns 48,251 shares of the company’s stock valued at $88,000 after acquiring an additional 41,780 shares during the last quarter. Finally, State Street Corp increased its holdings in shares of Stereotaxis by 5.7% during the 3rd quarter. State Street Corp now owns 680,612 shares of the company’s stock valued at $1,388,000 after acquiring an additional 36,518 shares during the last quarter. 45.35% of the stock is owned by hedge funds and other institutional investors.

Stereotaxis Trading Up 4.3 %

Shares of NYSEAMERICAN:STXS opened at $2.17 on Wednesday. Stereotaxis, Inc. has a 1-year low of $1.66 and a 1-year high of $3.29. The company has a market cap of $183.86 million, a PE ratio of -7.75 and a beta of 1.55.

Stereotaxis (NYSEAMERICAN:STXS) last posted its earnings results on Monday, November 11th. The company reported ($0.08) EPS for the quarter, missing the consensus estimate of ($0.05) by ($0.03). Stereotaxis had a negative return on equity of 162.54% and a negative net margin of 85.79%. The company had revenue of $9.20 million for the quarter, compared to the consensus estimate of $6.80 million. Research analysts expect that Stereotaxis, Inc. will post -0.26 EPS for the current year.

Stereotaxis Company Profile

Stereotaxis, Inc designs, manufactures, and markets robotic systems, instruments, and information systems for the interventional laboratory in the United States and internationally. Its robotic magnetic navigation (RMN) systems include the Genesis RMN and Niobe systems, which enable physicians to complete complex interventional procedures by providing image-guided delivery of catheters and guidewires through the blood vessels and chambers of the heart to treatment sites.